Proton pump inhibitors and the risk of pancreatic cancer

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Brusselaers N, Sadr-Azodi O, Engstrand L. Long-term proton pump inhibitor usage and the association with pancreatic cancer in Sweden. J Gastroenterol. 2020;55:453–61.

    CAS  Article  Google Scholar 

  2. 2.

    Lai S-W. Proton pump inhibitors and the risk of pancreatic cancer. Journal of gastroenterology. 2021:In press.

  3. 3.

    Pottegård A, Broe A, Hallas J, et al. Use of proton-pump inhibitors among adults: a Danish nationwide drug utilization study. Ther Adv Gastroenterol. 2016;9:671–8.

    Article  Google Scholar 

  4. 4.

    Brusselaers N, Wahlin K, Engstrand L, et al. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden. BMJ Open. 2017;7:e017739.

    Article  Google Scholar 

  5. 5.

    Matuz M, Benkő R, Engi Z, et al. Use of proton pump inhibitors in Hungary: mixed-method study to reveal scale and characteristics. Front Pharmacol. 2020;11:552102.

    CAS  Article  Google Scholar 

  6. 6.

    Lassalle M, Le Tri T, Bardou M, et al. Use of proton pump inhibitors in adults in France: a nationwide drug utilization study. Eur J Clin Pharmacol. 2020;76:449–57.

    CAS  Article  Google Scholar 

  7. 7.

    Halfdanarson OO, Pottegard A, Bjornsson ES, et al. Proton-pump inhibitors among adults: a nationwide drug-utilization study. Therap Adv Gastroenterol. 2018;11:1756284818777943.

    Article  Google Scholar 

  8. 8.

    Savarino V, Marabotto E, Zentilin P, et al. Proton pump inhibitors: use and misuse in the clinical setting. Exp Rev Clin Pharmacol. 2018;11:1123–34.

    CAS  Article  Google Scholar 

  9. 9.

    Brusselaers N, Engstrand L, Lagergren J. PPI use and oesophageal cancer: what if the results are true? Cancer Epidemiol. 2018;54:139–40.

    Article  Google Scholar 

  10. 10.

    Xie Y, Bowe B, Yan Y, et al. Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: cohort study. BMJ (Clinical research ed). 2019;365:l1580.

    Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Nele Brusselaers.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Brusselaers, N., Sadr-Azodi, O. & Engstrand, L. Proton pump inhibitors and the risk of pancreatic cancer. J Gastroenterol 56, 295–296 (2021). https://doi.org/10.1007/s00535-021-01761-8

Download citation